MedTrace Logo

ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults

NCT06333145 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-05-07

No results posted yet for this study

Summary

Exploring the ED90 of remimazolam in Drug-induced Sleep Endoscopy in adults at different BMI groups.

Conditions

  • Effect of Drug

Interventions

DRUG

Remimazolam

Exploring ED90 induced by remimazolam anesthesia in adults of different BMI groups undergoing drug-induced sleep endoscopy

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Aihua Du, Dr · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-04
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06333145 on ClinicalTrials.gov